Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2539 (LINC02539) is a non-coding RNA gene located in the human genome, producing a transcript classified as a long intergenic non-coding RNA. It does not encode a protein. Like other lincRNAs, it may play a role in post-transcriptional regulation, chromatin modification, or gene expression, but no specific biological or disease associations, molecular mechanisms, or therapeutic relevance have been attributed to LINC02539 in currently available scientific literature or bioinformatics databases[1][3]. The gene is listed under standard gene databases (GeneCards, NCBI), with its alternative name (RP11-356I2.2). No clinical, pharmacological, or biomarker utility is associated with LINC02539 as of this writing, and it is not considered a classical therapeutic target in drug discovery or translational medicine contexts[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2539 (LINC02539).